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Abstract
Background: Helicobacter pylori (H. pylori) infection is ubiquitous in sub-Saharan Africa, but
paradoxically gastric cancer is rare.
Methods: Sera collected during a household-based survey in rural Tanzania in 1985 were tested
for anti-H. pylori IgG and IgG subclass antibodies by enzyme immunoassay. Odds ratios (OR) and
confidence intervals (CI) of association of seropositivity with demographic variables were
computed by logistic regression models.
Results: Of 788 participants, 513 were aged ≤17 years. H. pylori seropositivity increased from 76%
at 0–4 years to 99% by ≥18 years of age. Seropositivity was associated with age (OR 11.5, 95% CI
4.2–31.4 for 10–17 vs. 0–4 years), higher birth-order (11.1; 3.6–34.1 for ≥3rd vs. 1st born), and
having a seropositive next-older sibling (2.7; 0.9–8.3). Median values of IgG subclass were 7.2 for
IgG1 and 2.0 for IgG2. The median IgG1/IgG2 ratio was 3.1 (IQR: 1.7–5.6), consistent with a Th2-
dominant immune profile. Th2-dominant response was more frequent in children than adults (OR
2.4, 95% CI 1.3–4.4).
Conclusion: H. pylori seropositivity was highly prevalent in Tanzania and the immunological
response was Th2-dominant. Th2-dominant immune response, possibly caused by concurrent
bacterial or parasitic infections, could explain, in part, the lower risk of H. pylori-associated gastric
cancer in Africa.
Background
In sub-Saharan Africa, Helicobacter pylori (H. pylori) infec-
tion is ubiquitous, with seroprevalence reaching 90% or
higher in many populations [1]. H. pylori is transmitted
from person-to-person, and transmission risk is high in
populations of low socioeconomic status, poor hygiene,
and limited access to clean water [2-4]. The most severe
consequence of chronic H. pylori infection is gastric aden-
ocarcinoma [1]. However, gastric cancer rates vary widely
worldwide and correlate imperfectly with H. pylori sero-
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by 5 years of age in sub-Saharan Africa [6,7], highlighting
the particularly young age of infection acquisition, and
therefore duration of infection. However, age-standard-
ized gastric cancer incidence rates are relatively low at 2–
21 per 100,000 person-years for both males and females
[8]. 
In Japan, seroprevalence increases more gradually with
age to a prevalence of 40% to 70% among adults [9,10],
but the age-standardized gastric cancer incidence rates are
substantially higher, ranging from 65–92 and 24–39 per
100,000 person-years among males and females, respec-
tively [8]. By comparison, seroprevalence estimates in the
U.S. range from 10 to 20% among adults [10,11], with the
age-standardized gastric cancer incidence rates being 6.6
and 2.6 per 100,000 person-years among white males and
females, respectively [8]. 
These statistics highlight a paradoxical deficit of gastric
cancer cases in sub-Saharan Africa, compared to Western
countries after controlling for age, the so-called "African
enigma" [12]. Gastric cancer deficits may be artifactual,
due to incomplete case ascertainment and competing
mortality [13,14]; however, those reasons do not explain
why gastric cancer rates vary in African populations that
have comparable access to medical care. Specifically, pop-
ulations residing in mountainous areas tend to have a
higher relative frequency of gastric cancer as compared to
populations residing in lowland areas [15].
Variation in gastric cancer rates within Africa, and else-
where, suggests the presence of modifying factors on H.
pylori-associated gastric cancer risk. In other words, out-
comes of H. pylori infection could be influenced by bacte-
rial, host, diet, or other environmental factors. One
hypothesis, based on animal studies, posits that bacterial
and/or parasitic infections modulate H. pylori-induced
gastric cancer risk [16], perhaps by altering the quality of
H. pylori-induced mucosal immunity in the stomach
[17,18]. H. pylori infection is thought to cause gastric can-
cer by eliciting vigorous T-helper (Th1) pro-inflammatory
cellular immune responses in gastric mucosa [16] and the
resulting mucosal injury is mediated by pro-inflammatory
cytokines and oxygen radicals secreted by infiltrating
chronic inflammatory cells [16,19]. Parasites and, to a
lesser extent, certain bacterial infections [18], elicit Th2
instead of Th1-dominant immune responses to thwart
their elimination [20] and could plausibly modulate H.
pylori-induced immune response towards one less damag-
ing to the gastric mucosa.
We hypothesized that persons living in high H. pylori-
prevalence areas with low gastric-cancer incidence in
Africa would therefore have Th2-type dominant H. pylori-
specific responses. To test this hypothesis, we evaluated H.
pylori seropositivity and H. pylori-specific IgG subclass
antibodies in a rural population in northern Tanzania,
where H. pylori infection was expected to be endemic and
gastric cancer incidence is thought to be low.
Subject selection and serological methods
The study subjects were residents of the North Mara Dis-
trict, located on the eastern shores of Lake Victoria in Tan-
zania, who participated in human immunodeficiency
virus (HIV) serological surveys from May through June,
1985 [21]. Participants provided individual verbal con-
sent, and parents provided verbal consent for their chil-
dren, to participate in serological surveys. Institutional
Review Boards gave ethical approval for the study. Partic-
ipants were recruited from households, defined as com-
pounds where individuals shared meals and had one
person designated as head. As previously observed [21],
polygamy was frequently practiced in this population and
headmen often had several wives. The households were
randomly selected from nine villages located either on
hills (n = 5) or in valleys (n = 4). Participants provided
sociodemographic information and gave a blood sample
[21]. The samples were stored at -80°C and were thawed
once before current testing. Samples from all but 10 par-
ticipants enrolled in the original study were available for
H. pylori serologic testing.
Anti-H. pylori antibodies were measured using an IgG
enzyme immunoassay (EIA) as previously reported [22-
24]. This assay has been validated in various populations,
including those from Africa and was shown to have high
sensitivity (89–96%) and specificity (92–97%), using
biopsy-proven H. pylori gastric mucosa infection as the
gold standard [22,23]. The tests were run in triplicate
using a standard 96-well microtiter plate and placing the
plates on a Benchmark microplate reader (BioRad, Her-
cules, CA). EIA cut-off values were derived using known
H. pylori-positive and negative control sera in which OD
values < 0.8 were considered to be negative, OD values
>1.3 were considered positive, and OD values between
0.8 and 1.3 were considered to be indeterminate, as previ-
ously described [22,24]. To determine the IgG antibody
subclasses (IgG1 or IgG2) in seropositive individuals, as a
marker of Th1/2-type cellular response [25], we used IgG
subclass EIAs to mouse anti-human IgG1 and mouse anti-
human IgG2 conjugated to HRP (Zymed Laboratory, San
Francisco, CA). In brief, pooled serum was used as a refer-
ence standard for the IgG subclasses. This standard was
titrated using each of the IgG subclass antibodies (i.e.
mouse anti human IgG1 and mouse anti human IgG2) to
determine the highest dilution at which reactivity could
still be detected and also remain linear on a standard
curve [22,23,26]. The maximal dilution for both IgG1 and
IgG2 subclasses was 1:25,600. The serum was assigned anPage 2 of 7
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performed as previously stated using positive controls
diluted to 1:25,600 based on the previously mentioned
standard curve and double the concentration at 1:12,800
dilution. The IgG subclass unit was calculated as ratio of
the OD490 of the individual sample to the OD490 of the
standard (i.e., IgG subclass unit = sample OD490/reference
OD490). These assays were modified to determine the
optimal concentration of antigen in serum and IgG conju-
gate that discriminated between H. pylori-positive and H.
pylori-negative samples. Each plate incorporated H. pylori-
specific IgG subclass positive and negative control sam-
ples. OD values for IgG1 and IgG2 subclasses were nor-
malized using standards previously reported [22]. We
calculated the ratio of IgG1/IgG2 subclasses to determine
phenotype of Th1/2-type cellular immune response.
Using a previously established criteria to determine Th1
vs. Th2-type response in African and western populations
[27,28], an IgG1/IgG2 ratio >1.0 suggests a Th2-(IgG1)-
dominant cellular immune response and a ratio ≤ 1.0 sug-
gests a Th1-(IgG2)-dominant response.
Statistical analysis
Associations between sociodemographic variables (sex,
age, village location) and H. pylori seropositivity were
determined using Chi-square or Fisher's exact tests.
Because of the high H. pylori seroprevalence, we grouped
persons with indeterminate status with seronegative indi-
viduals for the analysis. Odds ratios (OR) and 95% confi-
dence intervals (CI) of association of H. pylori
seropositivity with age, sex, birth-order were estimated
using logistic regression models (PROC GENMOD in SAS
9.1 software package; SAS Institute). Because children are
more likely to acquire infection from an infected older
sibling, we also estimated the association between serop-
ositivity of a younger child with status of the next-older
sibling on whom samples were available. We accounted
for intra-familial or intra-household correlations among
observations by using generalized estimating equations
(25). We used independence working correlation matrices
in the computations and checked results by also using
equi-correlated working correlations that assumed that
members in the same family would have equal correla-
tions. Both methods yielded similar results, so only the
results using independent working correlations are pre-
sented. Values of IgG1/IgG2 ratio among seropositive
individuals were log-transformed to obtain a normal dis-
tribution. We assessed the relationship between the log-
transformed IgG1/IgG2 ratio and age in linear regression
models. Age was used in the categories 0–4, 5–9, 10–17,
and 18+ years. A two-sided p-value < 0.05 was considered
statistically significant.
Results
Of 788 participants, 351 (44%) were male. The majority
513 (65%) were 17 years old or younger (Table 1). Only
2 subjects were HIV-positive, so this variable was not ana-
lyzed further. Overall, 725 (92%) subjects were seroposi-
tive for H. pylori antibody; 27 (3%) were seronegative and
36 (5%) were indeterminate. H. pylori seropositivity rose
steeply with age from 76% in children aged 0–4 years to
99% in adults (ptrend < 0.001; Table 1). H. pylori seroposi-
tivity was similar among males and females. Among chil-
dren, those aged 10–17 years were more likely to be H.
pylori seropositive compared to those aged 0–4 years (OR
11.5, 95% CI 4.2–31.4; Table 1). Similarly, children of
higher birth-order (≥3) were more likely to be seroposi-
tive compared to first-born children (OR 11.1, 95% CI
3.6–34.1; Table 1). In a multivariable model, both age
group and birth-order were independently associated
with H. pylori seropositivity (OR 6.3, 95% CI 1.3–31, for
10–17 vs. 0–4 years and OR 4.0, 95% CI 1.1–15, for ≥3rd
vs. 1st born). H. pylori seropositivity was marginally higher
in children with a seropositive next-older sibling com-
pared to those whose next-older sibling was seronegative
(OR 2.7, 95% CI 0.9–8.3). All 62 married men and their
113 wives were H. pylori seropositive. Their concordant
results precluded us from evaluating the association of
seropositivity between spouses and within parent-child
units. H. pylori seropositivity was not associated with loca-
tion of the village in valleys (OR 0.66; 95% CI 0.33–1.33).
Among seropositive individuals, the median values for
the IgG subclass antibodies were IgG1: 7.2 (inter-quartile
range [IQR]: 3.6–12.4) and IgG2: 2.0 (IQR: 1.4–3.2). The
median IgG1/IgG2 ratio was 3.1 (IQR: 1.7–5.6). Children
were more likely to have an IgG1/IgG2 ratio, consistent
with Th2-dominant immune response, compared with
adults (OR 2.4, 95% CI 1.3–4.4). In analyses excluding
seronegative individuals, the proportion of persons show-
ing Th2-dominant responses increased from 33% among
children aged 1 year to 100% among children 3–6 years
and then declined somewhat to 80% among subjects aged
45 years and older (Figure 1, panel A). Similarly, values of
the log-transformed IgG1/IgG2 ratio rapidly increased
with age to peak between 3–4 years and then reached a
plateau in the adult years (Figure 1, panel B). Models of
the log-transformed IgG1/IgG2 ratio that included age as
a quadratic did not fit the data better than models with
linear age (Pearson χ2-test = 0.72). The IgG1/IgG2 ratio
was unrelated to gender, birth order, or village location
(data not shown).
Discussion
We observed extremely high H. pylori seroprevalence in a
rural population in northern Tanzania. Seropositive indi-
viduals showed a high IgG1/IgG2 ratio, suggestive of Th2-
dominant H. pylori-specific immune responses. Our cross-Page 3 of 7
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rural Tanzania, and shows that seropositivity increases
steeply with age in childhood and is associated, among
children, with higher birth-order and with having a sero-
positive next-older sibling. These findings are consistent
with prior studies of H. pylori infection in highly endemic
areas [2,5]. A novel finding from our study is the Th2-
dominant H. pylori-specific immune responses, which
were strongest in children but were present also in adults.
As assessed by IgG subclass antibodies, the Th2-dominant
immune responses to H. pylori infection observed in this
rural Tanzanian population contrasts to Th1-dominant
responses reported in Western populations [27,29]. We
speculate that Th2-dominant H. pylori-specific immune
responses in this population can be modulated by concur-
rent infection with parasitic or bacterial infections as has
been observed in animal models [16,18]. Th2-dominance
rapidly increased with age and peaked between 3–7 years.
This trend with age may reflect a tendency for younger
children to have a Th2-dominant pattern or may be due to
a high frequency and burden of parasitic and bacterial
infections among children, or both. Parasite egg and/or
worm burden for schistosomiasis and soil-transmitted
helminths have been shown to peak at young ages in this
population [30].
Our study highlights one aspect of the gastric cancer para-
dox in Africa, i.e., early acquisition of H. pylori infection in
childhood and persistence of seropositivity into adult-
hood in an area where gastric cancer is relatively rare.
Competing mortality (causing deficits in the elderly pop-
ulation ≥ 60 years) has been advanced as one explanation
for the lower age-sex specific gastric cancer incidence in
sub-Saharan Africa compared to developed countries.
However, this explanation is not supported by data from
South Africa where life expectancy prior to the AIDS epi-
demic was 63 years [31]. Investigators at Shirati Hospital,
North Mara District, who serve our study population and
are actively engaged in cancer research [32], previously
reported gastric cancer to be rare. In an analysis of 279
malignancies seen at the Hospital from 1952–1965, only
12 (4.3%) were diagnosed as gastric cancer [33]. Con-
versely, gastric cancer is relatively more frequent on the
slopes of Mount Kilimanjaro, where it contributes ~15%
of malignancies [34]. Moreover, there are similar reports
of higher gastric cancer rates in mountainous or dry areas
elsewhere in Africa [15,35,36]. The variation in relative
frequency of gastric cancer in the context of similar H.
pylori prevalence, similar access to medical care, and simi-
lar life expectancy has led to the hypothesis that environ-
mental co-factors, perhaps diet (nitrates or fresh fruits and
Table 1: Frequency and risk of H. pylori seropositivity among persons residing in rural Tanzania (May to June, 1985)
Characteristic No. H. pylori positive/Total No. (%) OR 95% CI P value
Sex * 0.87
Female 402/436 (92%) Ref.
Male 322/351 (92%) 1.04 0.67–1.62
Age group, years* <0.001
0–4 138/181 (76%) Ref.
5–9 168/180 (93%) 4.4 2.42–7.81
10–17 148/152 (97%) 11.5 4.22–31.4
≥18 264/268 (99%) 20.6 7.57–56.2
Birth order† <0.001
1 79/105 (75%) Ref.
2 82/101 (91%) 3.3 1.7–6.8
≥3 136/139 (97%) 11.1 3.7–34
Next-older sibling ± 0.08
Seronegative 23/29 (79%) Ref.
Seropositive 189/208 (91) 2.70 0.90–8.34
Location of village 0.25
Hill 272/290 (94%) Ref.
Valley 453/498 (91%) 0.66 0.33–1.33
Abbreviations: OR odds ratio; CI Confidence Interval
* Sex is missing for one person and age is missing for 7 persons
† Only children with information on birth-order included in this analysis
± "Next-older sibling" refers to the next-older sibling of the case childPage 4 of 7
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have been convincingly implicated in Africa. An alterna-
tive hypothesis posits that enteric or other parasites may
influence gastric cancer risk [16]. This hypothesis is based
on the observations in mice that Helicobacter-induced gas-
tric atrophy, a precursor lesion to gastric cancer, improved
in mice concurrently infected with enteric parasites but
not in mice that were not. Improvements were associated
with concomitant down-regulation of the pro-inflamma-
tory responses due to a shift from Th1 toward Th2-domi-
nant cellular immune response in mice with concurrent
enteric parasite infection [16]. Our finding of Th2-domi-
nant immune response in H. pylori infected persons from
northern rural Tanzania, where gastric cancer is relatively
rare, is consistent with this hypothesis. Although we lack
data on parasite or colonic bacterial infections, it is rea-
sonable to assume that people who live in remote rural
African villages without access to running water or other
amenities, such as ours, are frequently infected with para-
sitic and/or bacterial conditions in addition to H. pylori
[30,37].
The role of Th1/2 immunity and H. pylori-induced gastric
cancer has been investigated in two prior studies. In one
conducted in Soweto, South Africa, where gastric cancer
incidence is low, found Th2-dominant H. pylori-specific
immune responses in blacks with gastric symptoms [27]
whereas study of symptomatic white subjects from Austria
and Germany, where gastric cancer incidence is high,
demonstrated Th1-dominant responses [27]. The authors
suggested that the Th2-dominant responses in blacks were
likely induced by co-infection with parasites, which they
postulated may modulate gastric risk cancer among Afri-
cans. In the other study conducted in Columbia in per-
sons from low and mountainous regions where gastric
cancer incidence is low and high, respectively, evaluated
H. pylori seropositivity and parasitic infections. Persons
from Tumaco, a low lying area where gastric cancer inci-
dence is low, had Th2-dominant immune responses and
a higher prevalence of helminth infections [28]. Con-
versely, those from Pasto, a high altitude area where gas-
tric cancer incidence is high, had predominantly Th1-
dominant immune responses and a lower prevalence of
Th2 type response by age group, in yearsFigure 1
Th2 type response by age group, in years: Panel A: Percent of H. pylori seropositive individuals with Th2-dominant IgG H. 
pylori specific immune response by age group. Panel B: Log-transformed IgG1/IgG2 ratio by age group among H. pylori serop-
ositive individuals in rural Tanzania. The X-axis shows age groups in years, the Y-axis shows log-transformed values. The y-line 
marks the cut-off value for T helper (Th)-dominant 1 vs. Th2-dominant response: values above the line indicate Th2-dominant 
responses, while values below the line indicate Th1-dominant responses. The line plot connects the median log-transformed 
IgG1/2 ratios for each age group and the scattered points indicate actual values for each age group.Page 5 of 7
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ences in Th1 or Th2-dominant responses across the low
vs. mountainous regions to differences the prevalence of
helminth infections and suggested that parasitic infection
may modify H. Pylori-induced gastric cancer risk in
Columbia. Thus, those studies and ours lend support to
the hypothesis that Th1/2 immunity modulated by para-
site infections may influence the risk of H. pylori-associ-
ated gastric cancer in diverse environments [15,28,35,36].
Our study has some limitations. H. pylori infection was
measured using serological assays, and some subjects may
have been misclassified. The finding of almost universal
seropositivity among adults is surprising because we
would have expected a small proportion of individuals to
be seronegative due to loss of bacterial colonization that
occurs with age in chronically infected persons or with
development of chronic gastric atrophy. We lacked endos-
copy data on the state of gastric mucosa (presence of ulcer,
gastric atrophy or not) and therefore are unable to draw
conclusions about the relationship between Th2 domi-
nance and severity of gastric mucosal inflammation.
Direct measurement of pepsinogen levels could have also
provided some information on the presence or not of gas-
tric atrophy, but the volume of residual samples from the
study population were inadequate for additional testing.
Furthermore, our study was cross-sectional so we cannot
infer temporality of associations demonstrated. We note
that our "highland" area villages were in low hills, not
mountainous areas, thus our study does not provide data
for Th1 vs. Th2 responses in low vs. mountainous regions
in Africa. The use of IgG subclasses assays as markers for
type1/2-dominant immune response in a general popula-
tion in Africa is novel, and our study provides valuable
baseline data for sub-Saharan Africa. Finally, IgE measure-
ments would strengthen our results on the role of para-
sites, but we lacked a validated assay to perform IgE
studies.
To conclude, H. pylori seropositivity was highly prevalent
in rural Tanzania. Seropositive persons showed a Th2-
dominant immune response to H. pylori infection, which
may be due to effects of concurrent infection with para-
sites and/or bacterial infections. We speculate that the
shifts in immune response from Th1 responses to Th2
responses in early childhood and persistence of that
immune profile into adulthood may partially explain the
paradoxically lower gastric cancer risk in highly H. pylori-
endemic Africa.
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